Plasma S100A8 and S100A9 Are Strong Prognostic Factors for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure

Figure 2

Association of plasma S100A8 and S100A9 levels with HBV-ACLF organ failure and disease progression. (a) Plasma S100A8 (b) and S100A9 distribution of HBV-ACLF patients with or without liver failure (LF), coagulation failure (CoF), kidney failure (KF), cerebral failure (CeF), respiratory failure (RF), and circulation failure (CF). (c) Comparison of plasma S100A8 and S100A9 between patients with or without BI. (d) Dynamic changes in plasma S100A8 and S100A9 between the initial (admission) and final (before death or discharge from the hospital or 28 days of diagnosis). Horizontal lines and error bars represent media ±95% confidence interval (CI).

(a)

(b)

(c)

(d)